Charts

25 Sep, 2022

News

23 Sep, 2022
The White Houseannounced $1.5 billionin funding to tackle opioid overdoses, sanctions against traffickers, and increased ...
23 Aug, 2022
Gainers Minerva Neurosciences (NASDAQ:NERV) stock rose 30.1% to $5.87 during Tuesday's after-market session. Trading volume for this ...
22 Aug, 2022
Gainers AnPac Bio-Medical Science (NASDAQ:ANPC) shares increased by 90.9% to $0.41 during Monday's regular session. ...
Cash is looking like it will outperform stocks, government bonds and corporate debt.
19 Aug, 2022
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock moved upwards by 83.1% to $0.69 during Friday's after-market session. Trading volume ...
Gainers Aeglea BioTherapeutics (NASDAQ:AGLE) stock increased by 64.8% to $0.83 during Friday's regular session. As ...
Rating Action: Moody's downgrades Endo's PDR to D-PD following Chapter 11 filingGlobal Credit Research - 19 Aug 2022New York, August 19, 2022 -- Moody's Investors Service ("Moody's") downgraded Endo Luxembourg Finance I Company S.a.r.l., and other subsidiaries of Endo International plc (together, "Endo") Probability of Default Rating (PDR) to D-PD from Ca-PD following company's filing for protection under Chapter 11 of the US Bankruptcy Code on August 16th. Moody's affirmed Endo's all other ratings including the Corporate Family Rating (CFR) at Caa3, the company's senior secured debt at Caa2, the secured 2nd Lien Regular Bond/Debenture at Ca, and the unsecured ratings at C. Concurrently, Moody's downgraded Speculative Grade Liquidity Rating to SGL-4 from SGL-3. At current levels of performance, with significant erosion in Vasostrict franchise, ongoing cash outflows related to various legal proceedings, and exposure to material opioid-related litigation claims, the company entered into a restructuring support agreement ("RSA") with Endo's first lien debt holders to reduce outstanding indebtedness.
Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's ...
Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares rose 88.3% to $0.9507 in pre-market trading after the company ...
A technical indicator suggests a bottom is in but fundamental forecasts sow concern
The pharmaceutical company, which filed for Chapter 11 bankruptcy protection, had the 320,000-square-foot complex built a decade ago.
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. Plus Therapeutics, ...
18 Aug, 2022
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 41.6% to $0.78 during Thursday's regular session. The ...
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66. Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) ...
Gainers Plus Therapeutics, Inc. (NASDAQ: PSTV) shares rose 88.7% to $1.04 in pre-market trading after the company was awarded ...
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 199.6% to close at $7.64 on Wednesday after the company announced ...
17 Aug, 2022
Gainers Endo International (NASDAQ:ENDP) stock moved upwards by 12.0% to $0.32 during Wednesday's after-market ...
A federal judge in Cleveland awarded $650 million in damages Wednesday to two Ohio counties that won a landmark lawsuit against national pharmacy chains CVS, Walgreens and Walmart, claiming the way they distributed opioids to customers caused severe harm to communities and created a public nuisance.
Endo International became the latest pharmaceutical company to file for bankruptcy under the weight of lawsuits alleging it played a role in fueling the opioid crisis.
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TJX Companies (TJX) stock is on the move Wednesday after releasing mixed results in its earnings report for Q2 of fiscal 2023. The post TJX Companies (TJX) Stock Moves on Mixed Q2 Earnings appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Endo International (ENDP) stock is taking a beating on Wednesday after the company filed for bankruptcy protection and revealed an RSA. The post What Is Going on With Endo International (ENDP) Stock Today? appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
The pharmaceutical company, which has its U.S. headquarters in Malvern, currently has debts totaling $8 billion.
Endo (ENDP) finally files for bankruptcy after negotiations with its debtholders as litigation claims continue to weigh on the business.
The generic drugmaker Endo International which faces thousands of lawsuits related to its alleged role in the opioid crisis, filed for bankruptcy late Tuesday morning, while announcing a plan to sell itself through a process administered by the bankruptcy court. As part of its plan, Endo (ticker: ENDP) secured an agreement from creditors to acquire the firm through a $6 billion credit bid. Other potential buyers could make higher offers through a process the company will ask the bankruptcy court to administer.
Endo International Plc(NASDAQ: ENDP)filed for bankruptcyafter reaching a $6 billion deal with some of its creditors ...
Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares moved upwards by 25.7% to $6.3 during Wednesday's pre-market ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We've got the news behind the biggest pre-market stock movers for Wednesday morning that traders need to know about this morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be ...
Endo International Plc filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its creditors, as the U.S. drugmaker seeks to settle thousands of lawsuits over its alleged role in the country's opioid epidemic. The pharmaceutical company is the latest to file for Chapter 11 to address opioid claims. Purdue Pharma, the maker of OxyContin, filed in September 2019, while Mallinckrodt Plc, a generic opioid manufacturer, recently emerged from bankruptcy.
The pharmaceutical company is the latest to file for Chapter 11 to address opioid claims. Purdue Pharma, the maker of OxyContin, filed in September 2019, while Mallinckrodt Plc, a generic opioid manufacturer, recently emerged from bankruptcy. The company's Chapter 11 bankruptcy filing in the Southern District of New York showed assets and liabilities in the range of $1 billion to $10 billion.
Endo International plc (NASDAQ: ENDP) ("Endo" or the "Company") today announced that it has entered into a restructuring support agreement ("RSA") with holders of more than a majority of Endo's first lien debt on a sale transaction that would substantially reduce outstanding indebtedness, address remaining opioid and other litigation-related claims, and best position Endo for the future. This will allow Endo to advance its business transformation with a strengthened balance sheet to create compe
10 Aug, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US ...
The drugmaker has been in talks with lenders, but also faces thousands of lawsuits from government and private plaintiffs alleging it fueled opioid addiction.
09 Aug, 2022
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Endo International reported a top- and bottom-line beat for its second quarter, but ENDP stock is plunging on bankruptcy fears. The post Endo International (ENDP) Stock Plunges Amid Bankruptcy Warning appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” It doesn’t matter if you have $500 or $5 million. Do this now.
Endo International plc's(NASDAQ: ENDP)Q2 sales decreased 20% to $569.11 million, beating the consensus of $529.94 ...
Gainers Verona Pharma (NASDAQ:VRNA) stock moved upwards by 35.8% to $9.44 during Tuesday's regular session. As of ...
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary ...
14:37
FinancialContent
Endo International (NASDAQ:ENDP) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:45 AM. Here's what ...
Endo (ENDP) delivered earnings and revenue surprises of 118.75% and 9.01%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SK Biopharmaceuticals, Co., Ltd. announced that Health Canada has accepted Paladin Labs Inc.'s filing of a New Drug Submission (NDS) for cenobamate as an adjunctive therapy for the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy. If Health Canada approves this NDS, Paladin Labs would be able to launch cenobamate in Canada.
Endo International plc (NASDAQ: ENDP) today reported financial results for the second-quarter ended June 30, 2022.
08 Aug, 2022
Kodiak Sciences Inc. (NASDAQ: KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; ...
Paladin Labs Inc., a subsidiary of Endo International plc (NASDAQ: ENDP), announced today that Health Canada has accepted its New Drug Submission (NDS) for cenobamate tablets as an adjunctive therapy for the management of partial-onset seizures in adults with epilepsy who are not satisfactorily controlled with conventional therapy. A decision from Health Canada as to whether cenobamate tablets can be marketed and sold in Canada under this NDS is expected mid-2023.
04 Aug, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average ...
03 Aug, 2022
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. Kaspien ...
Miller Value Partners, an investment management firm, published its “Miller Value Partners Income Strategy” second-quarter 2022 investor letter – a copy of which can be downloaded here. The Miller Income Strategy lost 17.7% in the second quarter of 2022, underperforming the 10.0% decline for the ICE BofA US High Yield Index. Go over the fund’s top 5 […]
28 Jul, 2022
Gainers ThermoGenesis Holdings (NASDAQ:THMO) stock moved upwards by 41.4% to $0.3 during Thursday's after-market session. At the ...
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently ...
27 Jul, 2022
Gainers Blue Water Vaccines (NASDAQ:BWV) shares increased by 57.6% to $3.23 during Wednesday's regular session. The ...
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a ...
26 Jul, 2022
Investors in Endo International plc (ENDP) saw new options begin trading this week, for the September 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new September 16th contracts and identified the following call contract of particular interest.
The Buxton Helmsley Group, Inc. (together with certain of its affiliates and clients, “BHG” or “we”), the New York City-based investment advisor to clients with financial interests in Endo International Plc. (“Endo” or the “Company”) (NASDAQ: ENDP),today issued an open letter to directors of the Company and its financial auditor, PricewaterhouseCoopers LLP, relating to financial disclosures..
21 Jul, 2022
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected ...
Gainers Addex Therapeutics (NASDAQ:ADXN) shares increased by 46.1% to $1.34 during Thursday's pre-market session. ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers traders need to know about! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Buy This $5 Stock BEFORE This Apple Project Goes Live The Best $1 Investment You Can Make Today Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air” Cash Holders Could Get Hit Hard THIS FRIDAY
Gainers Tuesday Morning Corporation (NASDAQ: TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. ...
18 Jul, 2022
Endo's (ENDP) subsidiary, Endo Ventures, signs agreement with Quoin Pharmaceuticals for developing/commercializing the latter's pipeline candidate, QRX003, for treating Netherton syndrome in Canada.
15 Jul, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NexImmune ReceivesIND ...
Endo affiliate, Paladin Labs, will commercialize Quoin’s lead asset for Netherton Syndrome in CanadaASHBURN, Va., July 15, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Inc. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, has entered into the License and Distribution Agreement and the Supply Agreement with Endo Ventures Limited, a subsidiary of Endo International plc (NASDAQ:ENDP), for the development, registration, supply, comm
14 Jul, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 22.1% to $0.2050 in pre-market trading. Allena Pharmaceuticals disclosed ...
13 Jul, 2022
Endo International Plc(NASDAQ: ENDP) is considering bankruptcy filing to restructure its more than $8 billion of debt and ...
Gainers Sharps Compliance Corp. (NASDAQ: SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be ...
12 Jul, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the ...
11 Jul, 2022
The Vanguard S&P Small-Cap 600 ETF is seeing unusually high volume in afternoon trading Monday, with over 1.1 million shares traded versus three month average volume of about 80,000. Shares of VIOO were down about 0.9% on the day.
06 Jul, 2022
Lending standards on mortgages may not be as tight as they seem.

Related Articles